Eyes on the Future: Innovating to improve the lives of those living with rare eye diseases this World Sight Day

Why Europe Needs a Biotech Act

Improving the Paediatric Framework: Aligning Ambition with Reality in the Revision of the General Pharmaceutical Legislation

The EU’s chance to lead the way on rare diseases: Seizing the opportunity of the WHA Resolution

From the EUCOPE Blog archives

Expanding PRIME: Ensuring Faster Access to Orphan Medicinal Products in the EU

February 27, 2025

The importance of achieving a 180-day assessment timeline for medicines

January 30, 2025

Vitality of the EU Biotech Sector Depends on a Positive EU Policy Direction

September 9, 2024

Trans-Atlantic Perspectives on the Future of Pharma

August 24, 2023

The European Health Data Space (EHDS): Ensuring the digital transformation of healthcare in Europe

July 26, 2023

To the archives